Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Unhealthy diet damages the development of immature fat cells, study shows

24 hours. This is all it takes for a so-called precursor fat cell to have its 'epigenetic recipe' on how to correctly develop into a mature fat cell, reprogrammed.

20 Apr 2018

Tattoo sensor: A needleless glucose monitor for diabetes patients

For Angela Valdez, being diagnosed with diabetes was an awakening. The disorder ran in her family, but she didn't think it would happen to her. And when it did, she acted by modifying her diet and physical activity. She was doing everything right--almost.

20 Apr 2018

People with vitamin D deficiency may be at greater risk of diabetes

An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing diabetes.

20 Apr 2018

Study shows testosterone deficiency in men is associated with chronic diseases

A male's total testosterone level may be linked to more than just sexual health and muscle mass preservation, a new study finds. Low amounts of the hormone could also be associated with chronic disease, even among men 40 years of age and younger.

19 Apr 2018

New microscopy techniques allow quasi-biochemical studies on living T cells

A joint study by the TU Wien and the Vienna School of Medicine has now led to a surprising result. While most opinion leaders in the field reasoned that T cell receptors must interact with one another for effective immune-signaling, the Viennese study shows: T cell receptors act alone. The study has now been published in the journal Nature Immunology.

19 Apr 2018

Genome editing identifies neural circuit behind leptin’s anti-obesity and anti-diabetes effects

Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural circuit in the hypothalamus as the primary mechanism in mediating leptin's anti-obesity and anti-diabetes effects and have identified two distinct mechanisms underlying leptin's inhibition of appetite.

19 Apr 2018

Faith-based diabetes support program launched by UTSA research team

Researchers at The University of Texas at San Antonio are taking diabetes education to church. Through the Building a Healthy Temple program, they're working with Hispanics who have type 2 diabetes to help them manage the disease and develop a healthier lifestyle.

18 Apr 2018

Study finds muscle complications among active young adults with Type 1 diabetes

A new study from McMaster and York universities has found that poor muscle health may be a complication of Type 1 diabetes, even among active twenty-somethings.

18 Apr 2018

Gene affects some women's body fat distribution and increases their diabetes risk

A natural variation of the gene KLF14 causes some women to store fat on their bellies and hips and puts them at significantly increased risk of type 2 diabetes, new research reveals.

17 Apr 2018

Study: Hot spots of type 1 diabetes found in food swamps

Hot spots of type 1 diabetes in New York City are found in food swamps, areas with a higher proportion of fast food restaurants, for children and adults with type 1 diabetes according to a new study published in the Endocrine Society's Journal of the Endocrine Society.

17 Apr 2018

Scientists provide insight into how gene associated with autoimmunity contributes to disease

Researchers have provided new insight into how a gene associated with autoimmunity contributes to disease in humans.

17 Apr 2018

Study compares survival outcomes of different drugs for type 2 diabetes

In a comparison of different classes of drugs used to lower blood sugar levels for patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT-2) inhibitors or glucagon-like peptide 1(GLP-1) agonists were associated with a lower risk of death than dipeptidyl peptidase 4 (DPP-4) inhibitors or control (placebo or no treatment).

17 Apr 2018